Skip to Content
scroll
CSL Behring biopharmaceutical company logo on headquarters building

CSL Limited (CSL)

ASX.CSL $269.79

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

ASX.CSL $269.79

20 MINUTE DELAYED

TODAY

0 %

1 YEAR RETURN

-4.99%

VOLUME

0

DIV YIELD

1.12%

PE RATIO

38.10

52 WEEK RANGE

240.10

319.78

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

269.79

Change

0.00 (0.00)

Bid / Ask

0.00 - 0.00

Volume

0

Volume (3mths avg)

17,485,360

Turnover

0

Open

0.00

Day Range

265.76 - 271.15

VWAP

0.00

Prev Close

269.79

Last Trade

06.10 29/06 (AEST)

i

KEY INFORMATION
Sector

Healthcare

Shares Issued

454,807,152

NTA/Share

42.34

Last Dividend

1.42

Dividend Ex Date

07 MAR 2022

Dividend Pay Date

06 APR 2022

i

BROKER CALLS

current

Mean

1.80

Target Price

0.00

BUY

i

CURRENT (USD)
Revenue

10,310.00

EBITDA

3,719.60

Profit

2,375.00

Earnings Per Share (EPS)

7.54

Dividend Per Share (DPS)

3.18

Yield %

1.12

Market Cap

132,002.00

Price to Earnings Ratio (P/E)

38.1

i

TARGET PRICE FORECAST

i

ESTIMATES (USD)
Revenue

10,707.86

EBITDA

3,511.85

Profit

2,296.93

Dividend Per Share (DPS)

2.11

Earnings Per Share (EPS)

4.94

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation (BUY)

1.80
OPINION
ACTION
image description

Business Summary

CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. CSL is also involved in research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. CSL's operating model for its two businesses, CSL Behring and Seqirus.
image description

Relevant suggested news and content from the site

Back to top